P933: INDIRECT TREATMENT COMPARISON OF ELRANATAMAB WITH BELMAF, SEL-DEX, AND REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MU...

por Mol, Isha, Hu, Yannan, Cappelleri, Joseph, Chu, Haitao, Aydin, Didem, Hlavacek, Patrick
Publicado 2023

Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured c...

por Ren, Jinma, Cislo, Paul, Cappelleri, Joseph C., Hlavacek, Patrick, DiBonaventura, Marco
Publicado 2023

Humanistic and economic burden of fibromyalgia in Japan

por Lee, Lulu K, Ebata, Nozomi, Hlavacek, Patrick, DiBonaventura, Marco, Cappelleri, Joseph C, Sadosky, Alesia
Publicado 2016

Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings

por Trocio, Jeffrey, Rosen, Virginia M, Gupta, Anu, Dina, Oluwaseyi, Vo, Lien, Hlavacek, Patrick, Rosenblatt, Lisa
Publicado 2018

A systematic review of the effectiveness of policies restricting access to pregabalin

por Stacey, Brett R., Liss, Jonathan, Behar, Regina, Sadosky, Alesia, Parsons, Bruce, Masters, Elizabeth T., Hlavacek, Patrick
Publicado 2017

PB2100: REAL-WORLD TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A RETROSPECTIVE CHART STUDY

por Guillaume, Xavier, Horchi, Dahbia, Gomez, Jorge, Hlavacek, Patrick, Ren, Jinma, Schepart, Alex, Aydin, Didem, Dibonaventura, Marco
Publicado 2023

Perspectives on the impact of painful diabetic peripheral neuropathy in a multicultural population

por Eichholz, Martin, Alexander, Andrea H., Cappelleri, Joseph C., Hlavacek, Patrick, Parsons, Bruce, Sadosky, Alesia, Tuchman, Michael M.
Publicado 2017

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity

por Cohen, Alexander, Sah, Janvi, Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Publicado 2021

State-specific, racial and ethnic heterogeneity in trends of firearm-related fatality rates in the USA from 2000 to 2010

por Kalesan, Bindu, Vasan, Sowmya, Mobily, Matthew E, Villarreal, Marcos D, Hlavacek, Patrick, Teperman, Sheldon, Fagan, Jeffrey A, Galea, Sandro
Publicado 2014

Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA

por Oguz, Mustafa, Lanitis, Tereza, Li, Xiaoyan, Wygant, Gail, Singer, Daniel E., Friend, Keith, Hlavacek, Patrick, Nikolaou, Andreas, Mattke, Soeren
Publicado 2019

Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis

por Cohen, Alexander, Keshishian, Allison, Lee, Theodore, Wygant, Gail, Rosenblatt, Lisa, Hlavacek, Patrick, Mardekian, Jack, Wiederkehr, Daniel, Sah, Janvi, Luo, Xuemei
Publicado 2021

P924: TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A REAL-WORLD OBSERVATIONAL CHART REVIEW S...

por Goyal, Ravi K, Frugier, Gaelle, Rombi, Julien, Esterberg, Lizzi, Davis, Keith, Hlavacek, Patrick, Ren, Jinma, Schepart, Alex, Aydin, Didem, Dibonaventura, Marco
Publicado 2023

All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants

por Deitelzweig, Steve, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Curtice, Tammy, Hlavacek, Patrick, Lingohr-Smith, Melissa, Menges, Brandy, Lin, Jay
Publicado 2018

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

por Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Publicado 2021

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease

por Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Delinger, Rachel, Yuce, Huseyin, Luo, Xuemei
Publicado 2021

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

por Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Publicado 2022

Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States

por Turakhia, Mintu P., Guo, Jennifer D., Keshishian, Allison, Delinger, Rachel, Sun, Xiaoxi, Ferri, Mauricio, Russ, Cristina, Cato, Matthew, Yuce, Huseyin, Hlavacek, Patrick
Publicado 2023

Association of Self-Efficacy and Outcome Expectations with Physical Activity in Adults with Arthritis

por Mielenz, Thelma J., Kubiak-Rizzone, Kathryn L., Alvarez, Kimberly J., Hlavacek, Patrick R., Freburger, Janet K., Giuliani, Carol, Mercer, Vicki S., Callahan, Leigh F.
Publicado 2013

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans...

por Din, Natasha, Fan, Jun, Schmitt, Susan, Guo, Jennifer D., Hlavacek, Patrick, Pundi, Krishna, Russ, Cristina, Emir, Birol, Turakhia, Mintu P., Perino, Alexander C.
Publicado 2023

Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Datab...

por Guo, Jennifer D., Rajpura, Jigar, Hlavacek, Patrick, Keshishian, Allison, Sah, Janvi, Delinger, Rachel, Mu, Qiao, Mardekian, Jack, Russ, Cristina, Okano, Gary J., Rosenblatt, Lisa
Publicado 2020